They reported increased transmigration and invasion in this CML cell subpopulation through overexpression of the αVβ3 integrin receptor leading to FAK/Akt pathway activation. The gene discussed is PTK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.